Aesthetic treatment around the eyes—here's what you should know
In a since-deleted TikTok video, California-based ceramic artist and product designer Esther Jeong recently took to the platform to share her story: Having travelled to South Korea to undergo the popular Juvelook treatment—an injectable designed to boost the skin's collagen—she immediately experienced a loss of vision in her left eye when the treatment was administered. Despite being quick to raise concern with her doctor, she was reassured that it was a temporary side effect.
Devastatingly, it turned out to be the opposite. Later seeking emergency treatment and consultation with ophthalmologists, Jeong was informed that branch arteries in her eyes had been blocked, leading to dead retinal tissue. Infuriatingly, Jeong was also told that her vision could've been saved had the treatment been reversed within two hours of being administered.
'I'm a designer and I'm a ceramic artist, and my livelihood is based off of what I see,' Jeong tearfully explained. Though she is now seeking compensation, the damage left by what Jeong thought was 'a very harmless skin booster' will endure. View this post on Instagram
A post shared by Dr. Muneeb Shah (@doctorly)
Aesthetic treatments are only becoming more popular, including those performed on the delicate eye area and treatments involving overseas travel. Vogue Singapore reached out to Dr Stephanie Ho, consultant dermatologist at Stephanie Ho Dermatology, for her advice on the risks and precautions to keep in mind when seeking these treatments. The eyes have it
'Aesthetic treatments to rejuvenate the thin skin area around eyes are commonly performed, as these areas often show signs of ageing earlier,' Ho explains. Such signs include eyelid laxity, fine lines, or a 'hollowing' appearance due to reduced fat and elasticity in the area.
Ho offers a rundown of the most common eye area treatments, including their potential side effects and precautions to take: Botox
What does it target? The appearance of crow's feet and frown lines, and promoting a brow lift effect.
Potential side effects Bruising, ptosis (upper eyelid drooping), dry eyes, heaviness of the brows or eyes, and headaches.
How can I minimise the risks? 'Go to a trained and experienced injector who administers such procedures regularly,' says Ho. 'Avoid blood thinning medications before treatment, and avoid pressure applied to the face and strenuous exercise in the first 24 hours after treatment.' Fillers
What does it target? Volume loss under the eyes and dark circles.
Potential side effects Bruising, bumps and lumpiness, the Tyndall effect (a blue tinge under the skin) and vascular occlusion (though rare, this can lead to blindness).
How can I minimise the risks? Again, Ho stresses the importance of seeing a trained, experienced injector. 'Their use of a blunt cannula is generally safer than when sharp needles are used,' Ho advises, while cautioning against fillers to high-risk areas such as the nose area, glabella and forehead. Ho also recommends avoiding permanent fillers: 'When dissolvable fillers are used, their effects can be reversed using hyaluronidase.' If you experience side effects including pain, blanching, a mottled skin appearance or changes to your vision, seek medical help immediately. Laser or micro needling treatments
What does it target? Improving skin texture, pigmentation, the appearance of wrinkles, and skin tightening.
Potential side effects Redness, swelling, crusting, infection, hyper- or hypopigmentation, scarring, burns or—in rare cases—eye injury.
How can I minimise the risks? You guessed it—as always, your choice of injector is key 'to ensure appropriate parameters and adequate intervals between treatments. Avoid excessive treatments with intervals that are too short—this can impair the skin barrier and cause sensitivity or side effects.' Sun exposure should be avoided before or after treatment, while it's of course essential to follow the pre- and post-care instructions given.
'Avoid inexperienced clinicians or unlicensed individuals who offer cheap prices, promise unrealistic results and use pressurising sales tactics,' says Ho of selecting the professional you work with. The skin around the eye area is thin and delicate, making it a part of the face that is commonly targeted when seeking aesthetic treatments. However, precautions should be taken. Frank Flores What conversations should I be having?
'An experienced and ethical clinician will be open and forthcoming about pre- and post-care, set realistic expectations, and address any safety concerns,' says Ho. 'They will be happy to answer any questions during the consultation and will not be pressurising, giving patients plenty of time to consider whether or not to proceed with treatment.'
Points that an experienced clinician will cover with their patients include: What concern/s is the patient hoping to address?
Realistic expectations about results.
Any underlying medical conditions, as well as side effects the patient may have previously experienced with aesthetic treatments.
Current medications such as blood thinners or retinoids.
Potential risks, complications and side effects will be discussed. The clinician should provide a breakdown of common risks, as well as rare but serious side effects (for example, vascular occlusion that may lead to blindness.)
Patients should feel free to ask questions, express any concerns, and have open and detailed discussions without being rushed or pressured. Ho recommends making sure the following questions are addressed: Who will be performing the procedure?
How many times have they performed the treatment?
Ask to see 'before' and 'after' photos if available.
What are the common side effects? Have serious side effects ever occurred? How were they managed?
How long is the treatment and what are the immediate side effects?
What is the downtime and what kind of recovery is expected?
Who should I contact if side effects occur, including out of hours? What side effects are normal?
Of course, with any aesthetic treatment, experiencing side effects is likely—it's most important to know what's to be expected, and therefore what isn't.
'For injectables such as Botox or fillers, normal side effects include mild swelling, tenderness or bruising at injection sites, and slight asymmetry or lumpiness early on as the filler settles in—especially for thinner-skinned areas such as under the eyes,' Ho shares. Most side effects will resolve within one to two weeks.
Meanwhile, normal side effects of lasers and micro needling include redness, peeling or crusting, skin sensitivity, and pinkness of the skin. Similarly, most of these side effects should recede within a one- to two-week timeframe.
Having an established idea of what side effects to expect before undergoing your treatment will help to provide ease of mind should you notice them, while making it easier to note what is out of the ordinary and therefore requires attention. Ho advises medical attention should be sought for side effects including: Severe or worsening pain in a localised area
Sudden vision changes, including double vision or problems with eye movement
Blanching (whitening) or unusual discolouration of skin, such as a mottled appearance
Progressive redness, pain, warmth or pustules
Fever or chills
Numbness or muscle weakness that does not improve
Worsening symptoms
'An experienced clinic will often provide their patients with a leaflet detailing the potential side effects of their specific treatment,' reiterates Ho. 'There will also be contact information for during and after office hours, while the clinic may contact their patients within 24 hours of the treatment to ensure there are no concerns. A patient shouldn't hesitate to contact their clinic for reassurance if they have worries about anything at all.'
Above all, as Ho's advice reflects, 'going to a trained and experienced specialist is the best way of minimising the risk of potential side effects.' Aesthetic treatments are becoming increasingly commonplace, and their benefits should outweigh the risks. While placing faith in a professional, keep yourself as informed as possible, and follow your instincts should something feel off. You may be the patient—but an ideal procedure will be in collaboration with you.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
an hour ago
- Straits Times
Forum: Efforts under way to encourage organisations, youth to support blood donations
Forum: Efforts under way to encourage organisations, youth to support blood donations We thank Mr Ivan Ong for advocating the importance of blood donation (More youth, corporate support needed for blood donations, June 4). Blood donation is a voluntary act, and time off for donating blood may be awarded at organisations' discretion. The Civil Service has taken the lead to allow public officers to use their volunteer leave for blood donation. This demonstrates the Civil Service's strong commitment to the National Blood Programme in securing the nation's blood supply. To galvanise more corporate involvement, Singapore Red Cross and the Health Sciences Authority actively collaborate with organisations to host community bloodmobile drives, conduct employee educational talks, and encourage group donations at any of the five Bloodbanks islandwide. We also encourage organisations and their chief executives to 'Adopt a Bloodbank' by pledging at least 40 staff donations every year. This initiative fosters long-term donor engagement and cultivates a sense of shared ownership and social responsibility in ensuring a safe and sufficient blood supply. To inspire more youth to step forward, our YouthInspire club works closely with interest groups and celebrity fan clubs to organise thematic drives at the Bloodbanks. These efforts not only promote peer-to-peer recruitment, but also help debunk misconceptions, and embed blood donation into the youth lifestyle. We invite youth to follow the @heybloodbuddy account on Instagram and TikTok and join our upcoming activities. We welcome all youth and community members to join our upcoming World Blood Donor Day celebration at Marina Bay Sands on June 28 themed, 'One Community, Many Lifesavers'. We thank all regular donors for their continued support and echo Mr Ong's call for more individuals and organisations to champion this life-saving cause. Together, we can ensure a resilient and sustainable national blood programme for all. Prakash Menon Srikumaran Group Director, Blood Donor Programme Singapore Red Cross Dr Ang Ai Leen Group Director, Blood Services Group Health Sciences Authority More on this Topic Forum: What readers are saying Join ST's Telegram channel and get the latest breaking news delivered to you.
Business Times
7 hours ago
- Business Times
Why China biotech is getting a DeepSeek moment, too
FROM artificial intelligence to military defence, China has offered a few DeepSeek moments this year, showing that the country is more than just the world's biggest factory, and that it also can compete with the United States on the technology front. Now biotech is having its own. In late May, Pfizer agreed to pay a record US$1.25 billion upfront to license an experimental cancer drug from Shenyang-based 3SBio, as well as making a US$100 million equity investment in the Hong Kong-listed biotech company. Two weeks later, Bristol-Myers Squibb said it would pay BioNTech US$1.5 billion guaranteed to license a similar cancer asset. It was a win for BioNTech, which bought Biotheus, the Chinese company that developed the drug, late last year for US$800 million. Increasingly, big pharmaceutical companies are seeing Chinese biotech as the disruptors. These two deals will allow Pfizer and Bristol-Myers Squib to go after Merck & Co's Keytruda, the world's top-selling medicine. 3SBio's drug works in the same way as a therapy from China's Akeso, which outperformed Keytruda in one trial. US-based Summit Therapeutics licensed Akeso's assets for US$500 million upfront in late 2022. Excitement These billion-dollar deals got bankers and investors excited. The Hang Seng Biotech Index is up about 60 per cent this year. By comparison, the S&P biotech index is down 6.5 per cent. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up There are good reasons to believe this rapid pace of dealmaking and enthusiasm for China biotech will last, with US President Donald Trump's economic policies serving as a major catalyst. Trump's threats to slash US prescription drug costs by '59 per cent, PLUS', as well as Medicaid and Medicare cuts in his big, beautiful tax and spending bill, will inevitably dent Big Pharma's bottom line. To cut in-house R&D expenses, these multinationals might have to come to China, where early-stage human tests are much cheaper and easier to run, despite comparable safety protocols. So far, the biotech industry is relatively insulated from Trump's tariffs, providing a meaningful safe haven for global investors. Rare earths materials and Boeing plane deliveries might be used as negotiation tools, but Beijing is making an exception for public health. It continues to welcome American-made medical supplies, including Pfizer's lung cancer drug Lorbrena and Merck's Gardasil, a HPV vaccine that protects against cervical cancer. Being in Beijing's good books allows Big Pharma to seal licensing deals with local partners. In addition, global drug companies and venture capital funds might want to take equity stakes too, just like Pfizer did last month. With a dip in biotech funding, especially in China, startups are unable to advance drugs on their own, and therefore demand large upfront licensing payments. This gives Western companies leverage to negotiate good deals. What is innovation without human talent? China's 'engineer dividend' is likely to pay off big time in the next few years, propelled by a hostile White House that vows to 'aggressively revoke' visas of Chinese studying in 'critical fields'. Already, the number of Chinese students in the US has dropped 22 per cent from its pre-pandemic peak, with many pointing to anti-Asian sentiment during Covid as a major drawback. Going forward, more could be forgoing US university degrees and working for promising startups at home instead. Between 2000 and 2020, the number of engineers in China ballooned from 5.2 million to 17.7 million, according to the State Council. The discipline and medicine are among the most popular fields for graduate studies. Those under the age of 30 account for 44 per cent of the total engineering pool, versus 20 per cent in the US, according to data compiled by Kaiyuan Securities. As a result, compensation for researchers is only about one-eighth that in the US. In other words, Chinese engineers are young, cheap and abundant. Tailwinds So what we've got are a lot of tailwinds: A group of strategic buyers eager to cut expenses and outsource research, a relatively benign local authority, and competitive talents. China's biotech industry is starting to dazzle. BLOOMBERG
Straits Times
11 hours ago
- Straits Times
Conflict and climate drive record global hunger in 2024, UN says
Conflict was the leading cause of hunger, impacting nearly 140 million people across 20 countries in 2024. PHOTO: AFP Conflict and climate drive record global hunger in 2024, UN says ROME - Acute food insecurity and child malnutrition rose for a sixth consecutive year in 2024, affecting more than 295 million people across 53 countries and territories, according to a UN report released on May 16. That marked a 5 per cent increase on 2023 levels, with 22.6 per cent of populations in worst-hit regions experiencing crisis-level hunger or worse. 'The 2025 Global Report on Food Crises paints a staggering picture,' said Mr Rein Paulsen, director of Emergencies and Resilience at the UN Food and Agriculture Organisation (FAO). 'Conflict, weather extremes and economic shocks are the main drivers, and they often overlap,' he added. Looking ahead, the UN warned of worsening conditions in 2025, citing the steepest projected drop in humanitarian food funding since the report's inception -– put at anywhere between 10 per cent and more than 45 per cent. US President Donald Trump has led the way, largely shutting down the US Agency for International Development (USAid), which provides aid to the world's needy, cancelling more than 80 per cent of its humanitarian programmes. 'Millions of hungry people have lost, or will soon lose, the critical lifeline we provide,' warned Ms Cindy McCain, the head of the Rome-based World Food Programme. Conflict was the leading cause of hunger, impacting nearly 140 million people across 20 countries in 2024, including areas facing 'catastrophic' levels of food insecurity in Gaza, South Sudan, Haiti and Mali. Sudan has confirmed famine conditions. Economic shocks, such as inflation and currency devaluation, helped push 59.4 million people into food crises in 15 countries – nearly double the levels seen prior to the Covid-19 pandemic – including Syria and Yemen. Extreme weather, particularly El Nino-induced droughts and floods, shunted 18 countries into crisis, affecting more than 96 million people, especially in Southern Africa, Southern Asia, and the Horn of Africa. The number of people facing famine-like conditions more than doubled to 1.9 million – the highest since monitoring for the global report began in 2016. Malnutrition among children reached alarming levels, the report said. Nearly 38 million children under five were acutely malnourished across 26 nutrition crises, including in Sudan, Yemen, Mali and Gaza. Forced displacement also exacerbated hunger. Nearly 95 million forcibly displaced people, including refugees and internally displaced persons, lived in countries facing food crises, such as Democratic Republic of Congo, Colombia. Despite the grim overall trend, 2024 saw some progress. In 15 countries, including Ukraine, Kenya and Guatemala, food insecurity eased due to humanitarian aid, improved harvests, easing inflation and a decline in conflict. To break the cycle of hunger, the report called for investment in local food systems. "Evidence shows that supporting local agriculture can help the most people, with dignity, at lower cost," Mr Paulsen said. REUTERS Find out more about climate change and how it could affect you on the ST microsite here.
